ERBB2 and breast carcinoma: The number of HER2+EVs in the supernatant of BT474 breast cancer cells was in the range of 2.5 × 102 per μl with a median HER2-expression level of 6 × 103 fluorescence intensity (Fig. 3h,i, suppl.